BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Q, Chen J, Gao H, Zhang S, Zhao C, Zhou C, Wang C, Li Y, Cai Z, Mou L. Drug repurposing: Ibrutinib exhibits immunosuppressive potential in organ transplantation. Int J Med Sci 2018;15:1118-28. [PMID: 30123049 DOI: 10.7150/ijms.24460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhu S, Jung J, Victor E, Arceo J, Gokhale S, Xie P. Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies. Front Oncol 2021;11:737943. [PMID: 34778053 DOI: 10.3389/fonc.2021.737943] [Reference Citation Analysis]
2 Zhang H, Qian M, Wang J, Yang G, Weng Y, Jin C, Li Y, Jin Y. Insights into the effects of difenoconazole on the livers in male mice at the biochemical and transcriptomic levels. J Hazard Mater 2022;422:126933. [PMID: 34425431 DOI: 10.1016/j.jhazmat.2021.126933] [Reference Citation Analysis]
3 Lo PC, Maeda A, Kodama T, Takakura C, Yoneyama T, Sakai R, Noguchi Y, Matsuura R, Eguchi H, Matsunami K, Okuyama H, Miyagawa S. The novel immunosuppressant prenylated quinolinecarboxylic acid-18 (PQA-18) suppresses macrophage differentiation and cytotoxicity in xenotransplantation. Immunobiology 2019;224:575-84. [PMID: 30967296 DOI: 10.1016/j.imbio.2019.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]